SEC Comment Letter 0000000000-24-013153 to BIOVIE INC. (BIVI)
BIOVIE INC.
Date: Nov. 26, 2024 · CIK: 0001580149 · Accession: 0000000000-24-013153
AI Filing Summary & Sentiment
Reasoning
File numbers found in text: 333-283394
Letter
November 26, 2024 Cuong Do Chief Executive Officer BioVie Inc. 680 W Nye Lane Suite 201 Carson City, NV 89703 Re:BioVie Inc. Registration Statement on Form S-1 Filed November 21, 2024 File No. 333-283394 Dear Cuong Do: This is to advise you that we have not reviewed and will not review your registration statement. Please refer to Rules 460 and 461 regarding requests for acceleration. We remind you that the company and its management are responsible for the accuracy and adequacy of their disclosures, notwithstanding any review, comments, action or absence of action by the staff. Please contact Jessica Dickerson at 202-551-8013 with any questions. Sincerely, Division of Corporation Finance Office of Life Sciences cc:Michael S. Lee, Esq.
Show Raw Text
November 26, 2024
Cuong Do
Chief Executive Officer
BioVie Inc.
680 W Nye Lane Suite 201
Carson City, NV 89703
Re:BioVie Inc.
Registration Statement on Form S-1
Filed November 21, 2024
File No. 333-283394
Dear Cuong Do:
This is to advise you that we have not reviewed and will not review your registration
statement.
Please refer to Rules 460 and 461 regarding requests for acceleration. We remind you
that the company and its management are responsible for the accuracy and adequacy of their
disclosures, notwithstanding any review, comments, action or absence of action by the staff.
Please contact Jessica Dickerson at 202-551-8013 with any questions.
Sincerely,
Division of Corporation Finance
Office of Life Sciences
cc:Michael S. Lee, Esq.